Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

Cipla Health's new 'W.H.O. hai toh woh ORS hai' campaign highlights the importance of knowing the correct ORS

Cipla Health Logo

News provided by

Cipla Health

30 Jul, 2026, 17:30 IST

Share this article

Share toX

Share this article

Share toX

The initiative aims to encourage informed ORS purchase by promoting awareness of W.H.O.-recommended formulations

MUMBAI, India, July 30, 2026 /PRNewswire/ -- On the occasion of World ORS Day, Cipla Health Limited has launched its annual awareness campaign for Prolyte ORS, aimed at encouraging consumers to understand the benefits of World Health Organization (W.H.O.) approved Oral Rehydration Solutions. Anchored in the message 'W.H.O. hai toh woh ORS hai' the campaign seeks to encourage consumers to look for the W.H.O. recommended mark on the pack while purchasing ORS.

While ORS has long been recognized as an important aid in managing dehydration, adoption gaps continue to persist. Data from the National Family Health Survey-5 (NFHS-5) shows that only around 62% of children under five suffering from diarrhoea received ORS, highlighting the need for greater awareness around dehydration management. Despite being easy to use and highly effective, ORS treatment rates continue to vary considerably across regions. Research has shown that many areas with a high prevalence of child diarrhoea continue to report low ORS treatment rates, and that although ORS is widely considered the primary treatment option for childhood diarrhoea, adherence to this recommendation remains far from optimal, creating a significant know-do gap between awareness and actual usage.

Internal Cipla Health data further indicates a continued need to strengthen consumer understanding around ORS. While awareness of ORS rises to nearly 70% when consumers are prompted, more than 75% of ORS-aware consumers are unable to recall what ORS stands for. Further, among aware users, only around 61% recalled seeing the 'W.H.O.-recommended' mark on pack, suggesting that while familiarity with ORS exists, awareness around formulations and what consumers should look for while purchasing ORS continues to evolve. Data from the engagements across Hyderabad and Mumbai showed the need for more knowledge amongst consumers around ORS. Only 85% respondents indicated they knew what to look for while purchasing an ORS product.

As part of the campaign, Cipla Health is undertaking a series of awareness initiatives designed to encourage consumers to understand what constitutes an appropriate ORS formulation. These include a hospital-led awareness initiative in association with MGM Group of Hospitals, where medical experts will engage with doctors, patients and caregivers on recognising dehydration, understanding the role of ORS in rehydration and the importance of choosing W.H.O. recommended formulations. The campaign will also feature educational content led by nutritionists and fitness creators, healthcare professional outreach programmes, consumer sampling activities, transit and outdoor visibility initiatives, and trade engagement efforts aimed at reinforcing the importance of choosing a W.H.O. recommended ORS formulation.

Shivam Puri, CEO, One India Business, Cipla, said, "As India experiences longer summers, rising temperatures, and a growing burden of heat-related illnesses, dehydration is becoming an increasingly critical public health challenge. While Oral Rehydration Solution (ORS) has remained the WHO-recommended gold standard for managing dehydration, awareness around choosing the right ORS formulation remains inconsistent. As category leaders, we have a responsibility that goes beyond providing solutions; we must empower people with the knowledge to make informed decisions. Through our efforts this year, we aim to close the awareness gaps, improve access to credible information, deepen understanding of global ORS standards, and reinforce the importance of evidence-based hydration practices. Our goal is simple: to help every Indian household recognize, choose, and trust scientifically validated hydration solutions when they matter most."

Commenting on the importance of hydration awareness, Dr. Usha Chennuru, Senior Director Medical Services at Cipla Health, said, "We commonly see that many people do not recognise the early signs of dehydration or understand the role ORS can play in managing it. Greater awareness and timely action can help people make more informed choices and take appropriate steps to manage dehydration effectively."

Among individuals engaged across activations in Hyderabad, 27% reported experiencing dehydration-related symptoms during outdoor activities like excessive sweating, and fever while 96% said these episodes had affected their productivity or day-to-day routine. The findings also revealed that 9% respondents were unaware of the role ORS can play in managing dehydration, highlighting the need for greater awareness around dehydration management and appropriate rehydration practices.

In Mumbai, Cipla Health along with a national medical association, and MGM Navi Mumbai Hospital engaged with 432 patients through awareness and counselling sessions in Mumbai. The interactions revealed that 31% participants were unaware of factors to consider while purchasing ORS.

About Cipla Health Limited:

Cipla Health Limited, the fast-moving wellness goods (FMWG) arm of Cipla, was incorporated in 2015 with a vision to spearhead the wellness wave in India. Cipla Health has delivered rapid growth and today plays across a diverse portfolio of 20 brands with most key brands being No. 1 or No. 2 in their respective categories. The portfolio includes products in Pain Care (Omnigel), Smoking Cessation (Nicotex), Oral Rehydration Solutions (Prolyte), Medicated Ointments (Cipladine), Cough & Cold (Cofsils and Naselin), Multi Vitamins (Maxirich), Weight Gain (Endura Mass) and Personal Care (Rivela Dermascience, Cetafresh, Tugain Essentials, Astaberry).

Modal title

Also from this source

Omnigel strengthens its portfolio with the introduction of Omnigel Maxstrong

Omnigel strengthens its portfolio with the introduction of Omnigel Maxstrong

Omnigel, Cipla Health's leading pain relief brand, has announced the launch of Omnigel Maxstrong, its latest offering in the pain relief segment. The ...

Cipla Health touches 1500+ lives through multi-city on-ground screening and awareness initiatives on World No Tobacco Day

Cipla Health touches 1500+ lives through multi-city on-ground screening and awareness initiatives on World No Tobacco Day

On the occasion of World No Tobacco Day, Cipla Health Limited is driving on-ground screening and awareness initiatives across Mumbai, Bangalore, and...

More Releases From This Source

Explore

Medical Pharmaceuticals

Medical Pharmaceuticals

Fitness/Wellness

Fitness/Wellness

Pharmaceuticals

Pharmaceuticals

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

News Releases in Similar Topics

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.